117 related articles for article (PubMed ID: 20022496)
1. Simocyclinone D8 turns on against Gram-negative bacteria in a clinical setting.
Richter SN; Frasson I; Palumbo M; Sissi C; Palù G
Bioorg Med Chem Lett; 2010 Feb; 20(3):1202-4. PubMed ID: 20022496
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticus.
Oppegard LM; Hamann BL; Streck KR; Ellis KC; Fiedler HP; Khodursky AB; Hiasa H
Antimicrob Agents Chemother; 2009 May; 53(5):2110-9. PubMed ID: 19273673
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of N-acetylcysteine against bacteria colonising central venous catheters.
Mansouri MD; Darouiche RO
Int J Antimicrob Agents; 2007 Apr; 29(4):474-6. PubMed ID: 17293092
[No Abstract] [Full Text] [Related]
5. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
Eke PI; Rotimi VO
Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
[TBL] [Abstract][Full Text] [Related]
6. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
7. The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance.
Tam VH; Louie A; Deziel MR; Liu W; Drusano GL
Antimicrob Agents Chemother; 2007 Feb; 51(2):744-7. PubMed ID: 17116679
[TBL] [Abstract][Full Text] [Related]
8. Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation.
Shaikh AR; Giridhar R; Yadav MR
Int J Pharm; 2007 Mar; 332(1-2):24-30. PubMed ID: 17174046
[TBL] [Abstract][Full Text] [Related]
9. Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.
Verghese J; Nguyen T; Oppegard LM; Seivert LM; Hiasa H; Ellis KC
Bioorg Med Chem Lett; 2013 Nov; 23(21):5874-7. PubMed ID: 24060488
[TBL] [Abstract][Full Text] [Related]
10. Microbiological spectrum and susceptibility pattern of clinical isolates from the neonatal unit in a single medical center.
Nitsch-Osuch A; Choroszy-Król I; Kuchar E; Korzeniewski K; Życińska K; Wardyn K
Adv Clin Exp Med; 2015; 24(1):15-22. PubMed ID: 25923082
[TBL] [Abstract][Full Text] [Related]
11. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
12. The discovery of biaryl acids and amides exhibiting antibacterial activity against Gram-positive bacteria.
Look GC; Vacin C; Dias TM; Ho S; Tran TH; Lee LL; Wiesner C; Fang F; Marra A; Westmacott D; Hromockyj AE; Murphy MM; Schullek JR
Bioorg Med Chem Lett; 2004 Mar; 14(6):1423-6. PubMed ID: 15006375
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems.
Rodríguez-Martinez JM; Conejo MC; Martínez-Martínez L; Cano ME; Velasco C; Pascual A
Clin Microbiol Infect; 2005 May; 11(5):402-4. PubMed ID: 15819868
[TBL] [Abstract][Full Text] [Related]
14. [Characterization of qnr gene for plasmid-mediated quionlone resistance].
Li CR; Lv X; Luo SF; Huang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Aug; 28(8):789-93. PubMed ID: 18080568
[TBL] [Abstract][Full Text] [Related]
15. Amino porphyrins as photoinhibitors of Gram-positive and -negative bacteria.
Sol V; Branland P; Chaleix V; Granet R; Guilloton M; Lamarche F; Verneuil B; Krausz P
Bioorg Med Chem Lett; 2004 Aug; 14(16):4207-11. PubMed ID: 15261271
[TBL] [Abstract][Full Text] [Related]
16. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
Eley A; Ibrahim M; Kurdi SE; Conlon JM
Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of some unsymmetrical diorganyltellurium(IV) dichlorides.
Soni D; Gupta PK; Kumar Y; Chandrashekhar TG
Indian J Biochem Biophys; 2005 Dec; 42(6):398-400. PubMed ID: 16955743
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity.
Franchini C; Muraglia M; Corbo F; Florio MA; Di Mola A; Rosato A; Matucci R; Nesi M; van Bambeke F; Vitali C
Arch Pharm (Weinheim); 2009 Oct; 342(10):605-13. PubMed ID: 19753564
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
Rai R; Chen HN; Czyryca PG; Li J; Chang CW
Org Lett; 2006 Mar; 8(5):887-9. PubMed ID: 16494466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
